The trademark application HiPM Human Purified Microbiota was filed by Microviable Therapeutics, a corporation established under the laws of the Kingdom of Spain (the "Applicant"). The application was published for oppositions on February 28, 2022, and it was registered by office on June 7, 2022 without any oppositions.
The application was filed in Spanish (English was selected as the second language).
Goods And Services
The mark was filed in class 1 with Probiotic bacteria for the food industry and Probiotic bacterial cultures for the food industry..
The mark was filed in class 5 with following description of goods:
Nutritive substances for microorganisms
Medicines for intestinal disorders
Veterinary preparations for treatment of intestinal bacteria
Probiotic preparations for medical use to help maintain a natural balance of flora in the digestive system
Pharmaceutical preparations for the prevention of disorders caused by bacteria
Pharmaceutical preparations for the treatment of diseases caused by bacteria
Pharmaceutical preparations for the treatment of disorders caused by bacteria
Pharmaceutical preparations for the prevention of diseases caused by bacteria
Immunotherapeutic agents for bacterial infections
Probiotic supplements
Pharmaceutical preparations for the treatment of digestive diseases
Medicines for the treatment of gastrointestinal diseases
Medicine
Pharmaceutical drugs
Biological preparations for the treatment of cancer
Pharmaceutical preparations for the treatment of autoimmune diseases
Pharmaceutical products for the treatment of infectious diseases
Pharmaceutical preparations for the prevention of inflammatory diseases
Pharmaceutical preparations for the prevention of autoimmune diseases
Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases
Pharmaceutical preparations for the prevention of diseases of the metabolic system
Pharmaceutical preparations for the treatment of inflammatory diseases
Pharmaceutical preparations for the prevention of inflammatory disorders
Pharmaceutical preparations for the treatment of inflammatory disorders
Pharmaceutical preparations for treating metabolic disorders
Pharmaceutical preparations for treating skin disorders
Pharmaceutical preparations for treating gastrointestinal disorders
Pharmaceutical preparations for the treatment of diseases of the metabolic system
Pharmaceutical preparations for the treatment of autoimmune disorders.
The mark was filed in class 42 with Research and development in the field of microorganisms and cells.